Quest Diagnostics Inc. (DGX)

84.73
0.75 0.88
NYSE : Health Services
Prev Close 85.48
Open 84.65
Day Low/High 84.42 / 85.53
52 Wk Low/High 85.27 / 116.49
Volume 149.27K
Avg Volume 1.26M
Exchange NYSE
Shares Outstanding 136.07M
Market Cap 12.01B
EPS 5.60
P/E Ratio 14.27
Div & Yield 2.12 (2.21%)

Latest News

Quest Diagnostics To Discuss Strategic Growth Drivers And Financial Outlook At 2018 Investor Day

Quest Diagnostics To Discuss Strategic Growth Drivers And Financial Outlook At 2018 Investor Day

-- Provides outlook for 2019-2022, extending the company's targeted 3-5% revenue compound annual growth rate (CAGR) and updating its adjusted earnings goal to a 4-6% CAGR

Quest Diagnostics To Build Flagship Laboratory At Visionary Campus In Clifton, New Jersey To Empower Better Health For Patients In Seven States

Quest Diagnostics To Build Flagship Laboratory At Visionary Campus In Clifton, New Jersey To Empower Better Health For Patients In Seven States

New lab to be the company's largest in country with more than 1,100 employees, featuring innovative design, automation and expanded capacity

Quest Diagnostics To Acquire The Laboratory Services Business Of Boyce And Bynum Pathology Laboratories, Expanding Diagnostic Innovation In The Midwest

Quest Diagnostics To Acquire The Laboratory Services Business Of Boyce And Bynum Pathology Laboratories, Expanding Diagnostic Innovation In The Midwest

Transaction aims to provide a broader range of clinical and pathology diagnostic services to patients, hospitals and physicians throughout Missouri and surrounding Midwestern states

Quest Diagnostics To Showcase New Data At The American Heart Association 2018 Scientific Sessions

Quest Diagnostics To Showcase New Data At The American Heart Association 2018 Scientific Sessions

New Findings Demonstrate the Benefit of Using Genetic Markers to Aid Detection of Atrial Fibrillation

Horizon Expands Laboratory Network, Adding Quest Diagnostics As Preferred Provider

Horizon Expands Laboratory Network, Adding Quest Diagnostics As Preferred Provider

- Quest to participate as in-network provider of laboratory services for Horizon Blue Cross Blue Shield of New Jersey plan participants

Quest Diagnostics, A Pioneer In Consumer Health, Expands Offering With Launch Of QuestDirect, A Service That Provides Consumers Access To Lab Testing Without Visiting A Doctor's Office

Quest Diagnostics, A Pioneer In Consumer Health, Expands Offering With Launch Of QuestDirect, A Service That Provides Consumers Access To Lab Testing Without Visiting A Doctor's Office

QuestDirect Builds on Quest's existing consumer offerings available through the new and improved MyQuest patient platform that lets people access their lab results, schedule appointments and pay bills

Quest Diagnostics Completes Acquisition Of U.S. Laboratory Services Business Of Oxford Immunotec

Quest Diagnostics Completes Acquisition Of U.S. Laboratory Services Business Of Oxford Immunotec

Oxford Immunotec's T-SPOT®.TB Tuberculosis and Accutix™ Tick-Borne Disease Testing Services are Part of Quest Diagnostics' Portfolio of Innovative Infectious Disease Diagnostics Tests, Broadening Access in the United States

Sonora Quest Laboratories Partners With UMETHOD Health To Advance The Care Of Chronic Diseases With Precision Medicine

Sonora Quest Laboratories Partners With UMETHOD Health To Advance The Care Of Chronic Diseases With Precision Medicine

Arizona's leading diagnostic provider offers first artificial intelligence-based precision medicine platform for Alzheimer's disease

Quest Diagnostics And Marin General Hospital To Improve Access To Innovative Diagnostic Services In Northern California

Quest Diagnostics And Marin General Hospital To Improve Access To Innovative Diagnostic Services In Northern California

Quest to Acquire the Outreach Laboratory Service Operations of Marin General Hospital

Quest Diagnostics To Host Investor Day On November 29, 2018

Quest Diagnostics To Host Investor Day On November 29, 2018

SECAUCUS, N.J.

Quest Diagnostics Reports Third Quarter 2018 Financial Results

Quest Diagnostics Reports Third Quarter 2018 Financial Results

-- Third quarter revenues of $1.89 billion, up 1.8% from 2017

Quest Diagnostics Acquires Hurley Medical Center's Outreach Laboratory Services Operation In Central Michigan

Quest Diagnostics Acquires Hurley Medical Center's Outreach Laboratory Services Operation In Central Michigan

Relationship to expand access to quality, high value and innovative services for people in Flint and surrounding communities

Quest Diagnostics To Present New Insights From Genetic Testing At The 2018 American Society Of Human Genetics Annual Meeting

Quest Diagnostics To Present New Insights From Genetic Testing At The 2018 American Society Of Human Genetics Annual Meeting

Four Presentations Reveal Genetic Insights from Quest's Advanced Diagnostics

Quest Diagnostics Completes Acquisition Of Provant Health, Extending Health And Wellness Services

Quest Diagnostics Completes Acquisition Of Provant Health, Extending Health And Wellness Services

Bolsters company's expert screening and intervention services for employers and managed populations

Quest Diagnostics Launches The Global Diagnostics Network (GDN) To Improve Healthcare By Increasing Access To Diagnostic Insights Around The World

Quest Diagnostics Launches The Global Diagnostics Network (GDN) To Improve Healthcare By Increasing Access To Diagnostic Insights Around The World

The GDN brings together leading diagnostics services providers to share expertise and drive worldwide diagnostics innovation

Quest Diagnostics Acquires PhenoPath, Broadening Access To Advanced Diagnostics

Quest Diagnostics Acquires PhenoPath, Broadening Access To Advanced Diagnostics

PhenoPath deepens Quest's presence in the Pacific Northwest while extending the company's capabilities in anatomic pathology and molecular oncology

Quest Diagnostics To Acquire U.S. Laboratory Services Business Of Oxford Immunotec

Quest Diagnostics To Acquire U.S. Laboratory Services Business Of Oxford Immunotec

Acquisition to broaden access to tuberculosis (TB) IGRA blood testing in the United States

Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics

Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics

Bolsters Quest's leadership in advanced diagnostics for women's and reproductive health

Quest Diagnostics Health Trends™ Study Finds Drug Misuse Rates Remain Constant At High Levels, And Dangerous Opioid-related Drug Combining Is Prevalent

Quest Diagnostics Health Trends™ Study Finds Drug Misuse Rates Remain Constant At High Levels, And Dangerous Opioid-related Drug Combining Is Prevalent

- More than half of Americans tested misused their prescription drugs in 2017

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J.

New Quest Diagnostics Data Shows Lyme Disease Prevalence Increasing And Is Now Present In New U.S. States

New Quest Diagnostics Data Shows Lyme Disease Prevalence Increasing And Is Now Present In New U.S. States

- Number of positive tests for Lyme disease increased significantly between 2016 and 2017.

TheStreet Quant Rating: B (Buy)